As of Dec 15
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 4.00, with a high estimate of 5.50 and a low estimate of 3.80. The median estimate represents a +50.38% increase from the last price of 2.66.
The current consensus among 6 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.